보령

003850KOSPI의약품 제조업

53.7 / 100

Reference Date: 2026-07-24

Financial Score18.5 / 40

News Sentiment19.2 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but the high debt ratio poses financial risk. Slightly down 3.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Boehringer focuses on strengthening its own product portfolio and building a stable portfolio centered on chronic diseases to enhance profitability. In 2024, the company achieved sales of 1.171 trillion KRW and operating profit of 70.5 billion KRW. It leverages manufacturing competitiveness, R&D capabilities, sales and marketing strength, and the LBA strategy to maintain global market competitiveness.

Number of Employees

1,645people

Average Salary

72.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

10.74Industry Average 11.235.0Point

In line with industry avg

PBR

0.84Industry Average 0.812.5Point

Higher than industry avg (caution)

ROE

7.89Industry Average 4.015.5Point

2.0x industry avg (good)

Debt Ratio

33.99Industry Average 12.430.0Point

2.7x industry avg (risky)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.2% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.6% (improving, 3yr)

Detailed News Sentiment

6 totalPositive 5Neutral 0Negative 1Average Sentiment Score 76.7

Positive
메디앙스, 46년 연구개발 역량으로 더마 베이비 스킨케어 시장 본격 확...
메디앙스의 강력한 R&D 역량이 보령의 더마 베이비 스킨케어 시장 진출에 긍정적 영향을 미칠 것으로 예상됩니다.
Positive
‘인수-생산-수출’ 선순환 전략… 보령 ‘글로벌 승부수’
보령의 글로벌 확장 전략이 긍정적 성과를 예고하며, 글로벌 빅파마와의 협력으로 생산 및 수출 능력 강화.
Positive
[우주 바이오 下] 빅파마 쫓는 K바이오…우주 신약 주권 노린다
보령제약 등 한국 바이오 기업들이 우주 환경을 활용해 신약 개발 비용과 시간을 절감하며 글로벌 경쟁력을 강화하고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 8,230Won52-week high 10,68052-week low 7,970

1-month return2.0Point

1m -3.52% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral[기재정정]사업보고서 (2025.12)2026-07-09